A5085803760- COVID-19 Clinical Research Studies
- Cardiac Imaging and Diagnostics
- Takotsubo Cardiomyopathy and Associated Phenomena
- Long-Term Effects of COVID-19
- Cardiac Valve Diseases and Treatments
- SARS-CoV-2 and COVID-19 Research
- COVID-19 and healthcare impacts
- Cardiovascular Function and Risk Factors
- Cardiac Health and Mental Health
- Cardiac Structural Anomalies and Repair
- COVID-19 and Mental Health
- Acute Myocardial Infarction Research
- Cardiac electrophysiology and arrhythmias
- Infective Endocarditis Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Pericarditis and Cardiac Tamponade
- Venous Thromboembolism Diagnosis and Management
- Cardiovascular Issues in Pregnancy
- Platelet Disorders and Treatments
- Neurosurgical Procedures and Complications
- Antiplatelet Therapy and Cardiovascular Diseases
- Emergency and Acute Care Studies
- Cardiovascular Disease and Adiposity
- Coronary Interventions and Diagnostics
- Heart Failure Treatment and Management
Complejo Hospitalario Universitario de Santiago
2019-2025
Complexo Hospitalario Universitario A Coruña
2019-2025
Complejo Hospitalario de Ourense
2021-2024
Universidade de Santiago de Compostela
2020-2024
Centro de Investigación en Red en Enfermedades Cardiovasculares
2020-2022
Centro de Investigación Biomédica en Red
2020-2022
Instituto de Investigación Sanitaria de Santiago
2020-2021
Fundación Instituto para la Mejora de la Asistencia Sanitaria
2021
Hospital Universitario de Getafe
2017-2020
Hospital Universitario Puerta de Hierro Majadahonda
2017
Background Takotsubo syndrome ( TTS ) is an acute reversible heart condition initially believed to represent a benign pathology attributable its self‐limiting clinical course; however, little known about prognosis based on different triggers. This study compared short‐ and long‐term outcomes between triggers, focusing various physical triggering events. Methods Results We analyzed patients with definitive diagnosis recruited for the Spanish National Registry (RETAKO [Registry Syndrome])....
Myocardial infarction with non-obstructive coronary arteries (MINOCA) is common and occurs in 6-8% of all patients fulfilling the diagnostic criteria for acute myocardial (AMI). This paper describes rationale behind trial 'Randomized Evaluation Beta Blocker ACE-Inhibitor/Angiotensin Receptor Treatment (ACEI/ARB) MINOCA patients' (MINOCA-BAT) need to improve secondary preventive treatment patients. METHODS: MINOCA-BAT a registry-based, randomized, parallel, open-label, multicenter 2:2...
The coronavirus disease 2019 (COVID-19) shows high morbidity and mortality, particularly in patients with concomitant cardiovascular diseases. Some of these are under oral anticoagulation (OAC) at admission, but to date, there no data on the clinical profile, prognosis risk factors such during hospitalization for COVID-19.
Heart disease is linked to worse acute outcomes after coronavirus 2019 (COVID-19), although long-term and prognostic factor data are lacking. We aim characterize the impact of underlying heart diseases surviving COVID-19 hospitalization.
Background Diabetes mellitus (DM) is one of the most frequent comorbidities in patients suffering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with a higher rate course disease (COVID-19). However, data about post-COVID-19 (PCS) DM are limited. Methods This multicenter, propensity score-matched study compared long-term follow-up cardiovascular, neuropsychiatric, respiratory, gastrointestinal, and other symptoms 8,719 to those without DM. The 1:1 score matching (PSM)...
Cardiovascular risk factors and usage of cardiovascular medication are prevalent among coronavirus disease 2019 (COVID-19) patients. Little is known about the implications COVID-19. The goal herein, was to evaluate prognostic impact having heart (HD) taking medications in a population diagnosed COVID-19 who required hospitalization. Also, we studied development events during hospitalization.Consecutive patients with definitive diagnosis made by positive real time- -polymerase chain reaction...
Background There is a paucity of outcome data on patients who are morbidly obese (MO) undergoing transcatheter aortic valve replacement. We aimed to determine their periprocedural and midterm outcomes investigate the impact obesity phenotype. Methods Results Consecutive MO (body mass index, ≥40 kg/m2, or ≥35 kg/m2 with obesity-related comorbidities; n=910) severe stenosis underwent replacement in 18 tertiary hospitals were compared nonobese cohort 18.5-29.9 n=2264). Propensity-score matching...
Drug-eluting stents (DES) are considered the therapy of choice in ST-segment elevation myocardial infarction (STEMI); however, a low persistent rate revascularizations and stent thrombosis exist over time. We have previously shown that paclitaxel (PTX)-drug-coated balloon (DCB) after bare-metal (BMS) implantation (DCB-combined strategy) yields superior angiographic clinical results compared to BMS short term. However, long-term safety efficacy this approach remain uncertain.An 8-year...
A definition of myocardial infarction with non-obstructive coronary arteries (MINOCA) was published by European Society Cardiology in 2016. The aim this study is to analyze the clinical profile and prognosis these patients a prospective single-center compare it literature data.During 3-year period, information from every consecutive MINOCA patient gathered (n = 109). It then compared 412 contemporaneous obstructive (MIOCA). Univariate multivariate analyses were performed. Prognosis analysis...
A systematic analysis of concomitant arterial hypertension in COVID-19 patients and the impact angiotensin-converting-enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARBs) have not been studied a large multicentre cohort yet. We conducted subanalysis from international HOPE Registry (https://hopeprojectmd.com, NCT04334291) comparing presence absence hypertension.Out 5837 patients, 2850 (48.8%) had diagnosis hypertension. 1978/2813 (70.3%) were already treated with ACEI ARBs. The...
Background: Acute cardiac injury (ACI) after COVID-19 has been linked with unfavorable clinical outcomes, but data on the impact of elevated troponin discharge during follow-up are scarce. Our objective is to elucidate outcome patients surviving a hospitalization. Methods: We conducted an analysis in prospective registry HOPE-2 (NCT04778020). Only discharged alive were selected for analysis, and all-cause death was considered as primary endpoint. As secondary endpoint, we established any...
Whether Takotsubo syndrome (TTS) should be classified within myocardial infarction with non-obstructive coronary arteries (MINOCAs) is still controversial. The aim of this work was to evaluate the main differences between TTS and non-TTS MINOCAs.A cohort study based on two prospective registries: from RETAKO registry (N:1,015) patients MINOCAs contemporary records acute five 5 national centers (N:1,080). Definitions management recommended by ESC were used. Survival analysis Cox regression...